Cassava Sciences | PTIE - 판매 및 관리 비용





판매 및 관리 비용 변화 날짜
Abbott USD 3.27B 138M 2026-03
Amgen USD 1.58B 354M 2026-03
Biogen USD 554.3M 128.2M 2026-03
Cara Therapeutics USD 2.19M 2.45M 2025-09
Cassava Sciences USD 3.89M 2.77M 2026-03
Eisai JPY 119.54B 7.82B 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Geron USD 35.42M 6.24M 2026-03
J&J USD 6.03B 719M 2026-03
Merck USD 2.67B 180M 2026-03
Novartis USD 3.14B 296M 2026-03
Novavax USD 25.53M 1.34M 2025-12
Pfizer USD 2.92B 1.16B 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12